Page last updated: 2024-12-06
tert-butylcyclohexane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 18508 |
| MeSH ID | M0153556 |
Synonyms (33)
| Synonym |
|---|
| LS-13880 |
| t-butylcyclohexane |
| einecs 221-652-4 |
| nsc 73719 |
| (1,1-dimethylethyl)cyclohexane |
| cyclohexane, tert-butyl- |
| cyclohexane,1-dimethylethyl)- |
| nsc-73719 |
| 1-tert-butylcyclohexane |
| nsc73719 |
| inchi=1/c10h20/c1-10(2,3)9-7-5-4-6-8-9/h9h,4-8h2,1-3h |
| 3178-22-1 |
| cyclohexane, (1,1-dimethylethyl)- |
| tert-butylcyclohexane |
| B0823 |
| tert-butyl-cyclohexane |
| unii-0rgt19ucq6 |
| 0rgt19ucq6 , |
| 4-t-butylcyclohexane |
| t-butyl cyclohexane |
| p-tert-butylcyclohexane |
| A820990 |
| AKOS006229396 |
| FT-0688502 |
| cyclohexane, t-butyl- |
| butylcyclohexane, tert- |
| DTXSID80185642 |
| mfcd00001471 |
| tert-butylcyclohexane, purum, >=97.0% (gc) |
| J-018537 |
| F17044 |
| Q27237139 |
| tert-butyl cyclohexane |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 50.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (50.50) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 3 (33.33%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (66.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||